MBRX icon

Moleculin Biotech
MBRX

Overview Fund Activity

26 hedge funds and large institutions have $5.61M invested in Moleculin Biotech in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VF
1
Virtu Financial
New York
$87K
2
SPC
2
Sigma Planning Corp
Michigan
$80K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$2.02M
4
Renaissance Technologies
4
Renaissance Technologies
New York
$62K
5
TSS
5
Two Sigma Securities
New York
$41K

Top Sellers

1
Truist Financial
1
Truist Financial
North Carolina
$0
2
RJA
2
Raymond James & Associates
Florida
$0
3
SFI
3
Susquehanna Fundamental Investments
Pennsylvania
$37K
4
UBS Group
4
UBS Group
Switzerland
$0
5
OQS
5
Occudo Quantitative Strategies
Florida
$41K
Name Holding Trade Value Shares
Change 		Shares
Change %
RJA
26
Raymond James & Associates
Florida
– -$43K -945 Closed
UBS Group
27
UBS Group
Switzerland
– -$4K -94 Closed
GRP
28
Global Retirement Partners
California
– -$1K -15 Closed
1
2